-
Something wrong with this record ?
Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia
A. Berková, L. Pavlištová, L. Babička, L. Houšková, J. Tajtlová, P. Baláži, E. Cmunt, J. Schwarz, J. Karban, M. Trněný, J. Březinová, Z. Zemanová, K. Michalová
Language English Country Slovakia
Grant support
NR9244
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
- MeSH
- Survival Analysis MeSH
- Chromosome Aberrations MeSH
- Leukemia, Lymphocytic, Chronic, B-Cell genetics MeSH
- Cytogenetic Analysis MeSH
- Molecular Diagnostic Techniques MeSH
- Financing, Organized MeSH
- In Situ Hybridization, Fluorescence MeSH
- Middle Aged MeSH
- Humans MeSH
- Chromosomes, Human, Pair 12 MeSH
- Chromosomes, Human, Pair 13 MeSH
- Chromosomes, Human, Pair 14 MeSH
- Mutation MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Immunoglobulin Heavy Chains genetics MeSH
- Trisomy MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
Interphase fluorescence in situ hybridization was used to detect common deletions in B-CLL patients as well as trisomy 12 and aberrations of IgH gene complex at 14q32.33 where we evaluated not only translocation-like signal pattern but also deletions. 120 (82%) patients showed genetic changes - del(13)(q14) 95 (62%), deletion of ATM gene 22 (15%), deletion of p53 gene 25 (17%) and trisomy 12 was proved in 18 (12%) cases. IgH rearrangements were detected in 45 (31%), split of the signals in 11 (8%), deletion of 3' segment flanking IgH gene in 5 (3%) and deletions of variable segment in 29 (20%) patients. Although deletions of 3' segment flanking IgH gene complex are supposed to have an adverse prognostic impact and the genetic background of variable segment deletions is believed to be most probably physiological, we assumed a detailed mapping of the 14q32.33 region will be needed to unravel these mysteries.
- 000
- 03055naa 2200577 a 4500
- 001
- bmc11006718
- 003
- CZ-PrNML
- 005
- 20241204113127.0
- 008
- 110405s2008 xo e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Berková, Adéla $7 xx0325890
- 245 10
- $a Combined molecular biological and molecular cytogenetic analysis of genomic changes in 146 patients with B-cell chronic lymphocytic leukemia / $c A. Berková, L. Pavlištová, L. Babička, L. Houšková, J. Tajtlová, P. Baláži, E. Cmunt, J. Schwarz, J. Karban, M. Trněný, J. Březinová, Z. Zemanová, K. Michalová
- 314 __
- $a Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, Faculty Hospital and First Faculty of Medicine, Charles University in Prague, Praha, Czech Republic. adelaberkova@yahoo.com
- 520 9_
- $a Interphase fluorescence in situ hybridization was used to detect common deletions in B-CLL patients as well as trisomy 12 and aberrations of IgH gene complex at 14q32.33 where we evaluated not only translocation-like signal pattern but also deletions. 120 (82%) patients showed genetic changes - del(13)(q14) 95 (62%), deletion of ATM gene 22 (15%), deletion of p53 gene 25 (17%) and trisomy 12 was proved in 18 (12%) cases. IgH rearrangements were detected in 45 (31%), split of the signals in 11 (8%), deletion of 3' segment flanking IgH gene in 5 (3%) and deletions of variable segment in 29 (20%) patients. Although deletions of 3' segment flanking IgH gene complex are supposed to have an adverse prognostic impact and the genetic background of variable segment deletions is believed to be most probably physiological, we assumed a detailed mapping of the 14q32.33 region will be needed to unravel these mysteries.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a chromozomální aberace $7 D002869
- 650 _2
- $a lidské chromozomy, pár 12 $7 D002881
- 650 _2
- $a lidské chromozomy, pár 13 $7 D002882
- 650 _2
- $a lidské chromozomy, pár 14 $7 D002883
- 650 _2
- $a cytogenetické vyšetření $7 D020732
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a těžké řetězce imunoglobulinů $x genetika $7 D007143
- 650 _2
- $a hybridizace in situ fluorescenční $7 D017404
- 650 _2
- $a chronická lymfatická leukemie $x genetika $7 D015451
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a diagnostické techniky molekulární $7 D025202
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a analýza přežití $7 D016019
- 650 _2
- $a trizomie $7 D014314
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Pavlištová, Lenka $7 xx0128185
- 700 1_
- $a Babická, Libuše $7 xx0118672
- 700 1_
- $a Houšková, Lucie $7 _BN001799
- 700 1_
- $a Tajtlová, Jana $7 xx0325907
- 700 1_
- $a Baláži, Peter $7 _AN062408
- 700 1_
- $a Cmunt, Eduard, $d 1952- $7 xx0106898
- 700 1_
- $a Schwarz, Jiří, $d 1957- $7 xx0052837
- 700 1_
- $a Karban, Josef $7 stk2007415539
- 700 1_
- $a Trněný, Marek, $d 1960- $7 nlk20000083659
- 700 1_
- $a Březinová, Jana, $d 1958- $7 xx0046958
- 700 1_
- $a Zemanová, Zuzana, $d 1962- $7 nlk20050170627
- 700 1_
- $a Michalová, Kyra, $d 1942- $7 nlk19990073558
- 773 0_
- $t Neoplasma $w MED00003470 $g Roč. 55, č. 5 (2008), s. 400-408 $x 0028-2685
- 910 __
- $a ABA008 $b A 1194 $y 7 $z 0
- 990 __
- $a 20110412125513 $b ABA008
- 991 __
- $a 20241204113122 $b ABA008
- 999 __
- $a ok $b bmc $g 834342 $s 698834
- BAS __
- $a 3
- BMC __
- $a 2008 $b 55 $c 5 $d 400-408 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
- GRA __
- $a NR9244 $p MZ0
- LZP __
- $a 2011-4B/ewme